Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Mayo Clinic Proceedings
|
December 4, 2009
Mature survival data for 176 patients younger than 60 years with primary myelofibrosis diagnosed between 1976 and 2005: evidence for survival gains in recent years
Rakhee Vaidya, Sergio Siragusa, Jocelin Huang, et al.
Leukemia & Lymphoma
|
December 19, 2017
Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study
Zanetta S Lamar, Andrew Dothard, LeAnne Kennedy, et al.
Leukemia & Lymphoma
|
September 6, 2023
Response and local control in patients treated with low-dose radiotherapy for tumoral mycosis fungoides
Joseph Pena, Deborah Cull, Lindsay C Strowd, et al.
Blood
|
April 1, 2011
Monosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survival
Rakhee Vaidya, Domenica Caramazza, Kebede H Begna, et al.
Blood
|
September 2, 2011
Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients
Ayalew Tefferi, Thitina Jimma, Naseema Gangat, et al.
Leukemia & Lymphoma
|
September 16, 2020
Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantation
Timothy J Voorhees, Kavya K Kannan, Jonathan Galeotti, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 5, 2016
Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma
Zanetta S Lamar, Nora Fino, Jodi Palmer, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 6, 2025
Cognitive Performance in Patients With Multiple Myeloma Treated With an Autologous Stem Cell Transplant: Results of the Brilliant Study
Cesar Rodriguez, Melanie Tam, David Hurd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status
Naseema Gangat, Domenica Caramazza, Rakhee Vaidya, et al.
Mayo Clinic Proceedings
|
January 4, 2012
One thousand patients with primary myelofibrosis: the mayo clinic experience
Ayalew Tefferi, Terra L Lasho, Thitina Jimma, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Mayo Clinic Proceedings
|
December 4, 2009
Mature survival data for 176 patients younger than 60 years with primary myelofibrosis diagnosed between 1976 and 2005: evidence for survival gains in recent years
Rakhee Vaidya, Sergio Siragusa, Jocelin Huang, et al.
Leukemia & Lymphoma
|
December 19, 2017
Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study
Zanetta S Lamar, Andrew Dothard, LeAnne Kennedy, et al.
Leukemia & Lymphoma
|
September 6, 2023
Response and local control in patients treated with low-dose radiotherapy for tumoral mycosis fungoides
Joseph Pena, Deborah Cull, Lindsay C Strowd, et al.
Blood
|
April 1, 2011
Monosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survival
Rakhee Vaidya, Domenica Caramazza, Kebede H Begna, et al.
Blood
|
September 2, 2011
Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients
Ayalew Tefferi, Thitina Jimma, Naseema Gangat, et al.
Leukemia & Lymphoma
|
September 16, 2020
Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantation
Timothy J Voorhees, Kavya K Kannan, Jonathan Galeotti, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 5, 2016
Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma
Zanetta S Lamar, Nora Fino, Jodi Palmer, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 6, 2025
Cognitive Performance in Patients With Multiple Myeloma Treated With an Autologous Stem Cell Transplant: Results of the Brilliant Study
Cesar Rodriguez, Melanie Tam, David Hurd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status
Naseema Gangat, Domenica Caramazza, Rakhee Vaidya, et al.
Mayo Clinic Proceedings
|
January 4, 2012
One thousand patients with primary myelofibrosis: the mayo clinic experience
Ayalew Tefferi, Terra L Lasho, Thitina Jimma, et al.
Page
of 3